PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models

Keith Dredge, Ian Bytheway, Vito Ferro(The University of Queensland), Edward Hammond(American Cancer Society), Thomas J. Gonda(University of South Australia), Maree T. Smith(The University of Queensland), Paul Handley, Ralf Brandt(Calvary Wakefield Hospital), Christina Vincent(Calvary Wakefield Hospital)
British Journal of Cancer
February 1, 2011
Cited by 165


Related Papers